EUVIMEDEUVIMED entdecken
Open Access

Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma

Ory Haisraely, Maayan Sivan, Zvi Symon, M Ben-Ayun, L Tsvang, J Kraitman, S Dubinsky, M Siman-Tov, D Benjamin, Yaacov Lawrence, Zvi Cohen, Anton Wohl und 2 weitere

Reports of Practical Oncology and Radiotherapy · 2024

DOI: 10.5603/rpor.100385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, 2024. Verfasst von Ory Haisraely und 13 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Unit, Judisman Oncology Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Simultaneous involvement of multiple distinct brain regions occurs in 2–5% of all high-grade gliomas (HGG) and is associated with poor prognosis. Whereas radiotherapy (RT) is an important and well-established treatment for high-grade glioma, the role of dose-escalated radiotherapy has yet to be established. In this case series, we report upon the dosimetry, adverse effects, and response in patients with multiple un-methylated high-grade gliomas receiving dose-escalated radiation. Materials and methods: We reviewed charts of patients with multifocal high grade glioma treated at our institution since January 2022. All patients had stereotactic biopsies after an magnetic resonance imaging (MRI) contrast-enhanced with T1, T2, FLAIR sequences and were discussed in a multidisciplinary oncology team. MGMT-positive patients received either TMZ alone or RT with TMZ and were excluded from this analysis. Un-methylated patients received dose-escalated RT without temezolamide (TMZ). Following computed tomography (CT) and MR simulation, the gros tumor volume (GTV) was delineated and prescribed 52.5 Gy in 15 fractions within the standard 40.05 Gy planning treatment volume (PTV). Treatment planning was volumetric modulated arc therapy.

Results

A total of 20 patients with multiple un-methylated MGMT glioblastoma multiforme were treated with dose-escalated radiation therapy between January 2022 and June 2023. All patients completed dose escalated radiotherapy without acute adverse effects. Progression-free survival at six months was 85%, as defined by the RANO criteria.

Conclusion

In this case series, we showed that un-methylated multiple high-grade glioma could be safely treated with dose escalation. Results of progression-free survival should be validated in a larger prospective clinical trial.

Schlagwörter

Stichwörter der Autor:innen

dose escalationhigh-grade gliomamultiple gliomaun-methylated MGMT

Autor:innen und Institutionen

  • Radiation Oncology Unit, Judisman Oncology Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
  • School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Neuro-Surgical Departments, Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Neuro-Oncology Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.

Zitieren

APA

Haisraely, O., Sivan, M., Symon, Z., Ben-Ayun, M., Tsvang, L., Kraitman, J., Dubinsky, S., Siman-Tov, M., Benjamin, D., Lawrence, Y., Cohen, Z., Wohl, A., Kaisman-Elbaz, T., & Taliansky, A. (2024). Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.100385

Vancouver

Haisraely O, Sivan M, Symon Z, Ben-Ayun M, Tsvang L, Kraitman J, et al. Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma. Reports of Practical Oncology and Radiotherapy. 2024. doi:10.5603/rpor.100385

BibTeX
@article{Haisraely2024,
  author = {Haisraely, Ory and Sivan, Maayan and Symon, Zvi and Ben-Ayun, M and Tsvang, L and Kraitman, J and Dubinsky, S and Siman-Tov, M and Benjamin, D and Lawrence, Yaacov and Cohen, Zvi and Wohl, Anton and Kaisman-Elbaz, Thila and Taliansky, Alisa},
  title = {Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma},
  journal = {Reports of Practical Oncology and Radiotherapy},
  year = {2024},
  doi = {10.5603/rpor.100385}
}
Kostenlos starten →